Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zinc Finger-DNA Recognition: Crystal Structure of a Zif268-DNA Complex at 2.1 Å
Pavletich, N. P., & Pabo, C. O. (1991) · Science · doi:10.1126/science.2028256 · Cited by 2,061
DNA duplication associated with Charcot-Marie-Tooth disease type 1A
Lupski, J. R., de Oca-Luna, R. M., Slaugenhaupt, S., Pentao, L., Guzzetta, V., Trask, B. J., Saucedo-Cardenas, O., Barker, D. F., Killian, J. M., Garcia, C. A., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90613-4 · Cited by 1,333
Self-citationDNA deletion associated with hereditary neuropathy with liability to pressure palsies
Chance, P. F., Alderson, M. K., Leppig, K. A., Lensch, M. W., Matsunami, N., Smith, B., Swanson, P. D., Odelberg, S. J., Disteche, C. M., & Bird, T. D. (1993) · Cell · doi:10.1016/0092-8674(93)90058-x · Cited by 814
Krox-20 controls myelination in the peripheral nervous system
Topilko, P., Schneider-Maunoury, S., Levi, G., Baron-Van Evercooren, A., Chennoufi, A. B. Y., Seitanidou, T., Babinet, C., & Charnay, P. (1994) · Nature · doi:10.1038/371796a0 · Cited by 794
Three-Dimensional Solution Structure of a Single Zinc Finger DNA-Binding Domain
Lee, M. S., Gippert, G. P., Soman, K. V., Case, D. A., & Wright, P. E. (1989) · Science · doi:10.1126/science.2503871 · Cited by 627
Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a)
Raeymaekers, P., Timmerman, V, Nelis, E., De Jonghe, P., Hoogenduk, J. E., Baas, F., Barker, D. F., Martin, J. J., De Visser, M., Bolhuis, P. A., et al. (1991) · Neuromuscular Disorders · doi:10.1016/0960-8966(91)90055-w · Cited by 607
Swiatek, P. J., & Gridley, T. (1993) · Genes & Development · doi:10.1101/gad.7.11.2071 · Cited by 463
Disruption of Krox-20 results in alteration of rhombomeres 3 and 5 in the developing hindbrain
Schneider-Maunoury, S., Topilko, P., Seitanidou, T., Levi, G., Cohen-Tannoudji, M., Pournin, S., Babinet, C., & Charnay, P. (1993) · Cell · doi:10.1016/0092-8674(93)90329-o · Cited by 458
A gene encoding a protein with zinc fingers is activated during G0/G1 transition in cultured cells.
Chavrier, P., Zerial, M., Lemaire, P., Almendral, J., Bravo, R., & Charnay, P. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02780.x · Cited by 415
Proposed structure for the zinc-binding domains from transcription factor IIIA and related proteins.
Berg, J. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.1.99 · Cited by 405
Cited by
Molecular biology of amyotrophic lateral sclerosis: insights from genetics
Pasinelli, P., & Brown, R. H. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1971 · Cited by 1,107
Protean PTEN: Form and Function
Waite, K. A., & Eng, C. (2002) · The American Journal of Human Genetics · doi:10.1086/340026 · Cited by 457
“…is part of a multigene family that contains C2H2-type zinc-finger proteins (Joseph et al. 1998), and germline mutations in this transcription factor gene have been implicated in Charcot-Marie-Tooth syndrome (MIM 118200) and congenital hypomyelinating neuropathy (MIM 605253) (Warner et al. 1998).”
BackgroundO'Donovan, K. J., Tourtellotte, W. G., Millbrandt, J., & Baraban, J. M. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01343-5 · Cited by 457
Egr-2 and Egr-3 are negative regulators of T cell activation
Safford, M., Collins, S., Lutz, M. A., Allen, A., Huang, C.-T., Kowalski, J., Blackford, A., Horton, M. R., Drake, C., Schwartz, R. H., et al. (2005) · Nature Immunology · doi:10.1038/ni1193 · Cited by 445
Mersiyanova, I. V., Perepelov, A. V., Polyakov, A. V., Sitnikov, V. F., Dadali, E. L., Oparin, R. B., Petrin, A. N., & Evgrafov, O. V. (2000) · The American Journal of Human Genetics · doi:10.1086/302962 · Cited by 421
Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway
Unoki, M., & Nakamura, Y. (2001) · Oncogene · doi:10.1038/sj.onc.1204608 · Cited by 381
Disease mechanisms in inherited neuropathies
Suter, U., & Scherer, S. S. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1196 · Cited by 348
Azzedine, H., Bolino, A., Taïeb, T., Birouk, N., Di Duca, M., Bouhouche, A., Benamou, S., Mrabet, A., Hammadouche, T., Chkili, T., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375034 · Cited by 314
Le, N., Nagarajan, R., Wang, J. Y. T., Araki, T., Schmidt, R. E., & Milbrandt, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407836102 · Cited by 300
Lapunzina, P., Aglan, M., Temtamy, S., Caparrós-Martín, J. A., Valencia, M., Letón, R., Martínez-Glez, V., Elhossini, R., Amr, K., Vilaboa, N., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.05.016 · Cited by 289
Frevel, M. A. E., Bakheet, T., Silva, A. M., Hissong, J. G., Khabar, K. S. A., & Williams, B. R. G. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.425-436.2003 · Cited by 288
The PMP22 Gene and Its Related Diseases
Li, J., Parker, B., Martyn, C., Natarajan, C., & Guo, J. (2013) · Molecular Neurobiology · doi:10.1007/s12035-012-8370-x · Cited by 280
EGR2 Mutations in Inherited Neuropathies Dominant-Negatively Inhibit Myelin Gene Expression
Nagarajan, R., Svaren, J., Le, N., Araki, T., Watson, M., & Milbrandt, J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00282-3 · Cited by 273
Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies
Nelis, E., Haites, N., & Van Broeckhoven, C. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(1999)13:1<11::aid-humu2>3.0.co;2-a · Cited by 230
Periaxin Mutations Cause Recessive Dejerine-Sottas Neuropathy
Boerkoel, C. F., Takashima, H., Stankiewicz, P., Garcia, C. A., Leber, S. M., Rhee-Morris, L., & Lupski, J. R. (2001) · The American Journal of Human Genetics · doi:10.1086/318208 · Cited by 220
“We previously hypothesized that, because mutations of the transcription factor EGR2 cause myelinopathies, mutation of genes regulated by EGR2 might also result in myelinopathies (Warner et al. 1998).”
BackgroundSelf-citationKrox20 stimulates adipogenesis via C/EBPβ-dependent and -independent mechanisms
Chen, Z., Torrens, J. I., Anand, A., Spiegelman, B. M., & Friedman, J. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.009 · Cited by 209
“It has also been established that Krox20 expression is essential for the final differentiation of myelinating Schwann cells (Zorick et al., 1996; Warner et al., 1998).”
BackgroundBerger, P., Niemann, A., & Suter, U. (2006) · Glia · doi:10.1002/glia.20386 · Cited by 181
“A recessive mutation is located in the R1 domain of EGR2/Krox20 and may affect the interaction between EGR2/Krox20 and the NAB proteins that regulate EGR2/Krox20 activity (Warner et al., 1998).”
BackgroundSenderek, J., Bergmann, C., Stendel, C., Kirfel, J., Verpoorten, N., De Jonghe, P., Timmerman, V., Chrast, R., Verheijen, M. H. G., Lemke, G., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/379525 · Cited by 178
Yamada, K., Gerber, D. J., Iwayama, Y., Ohnishi, T., Ohba, H., Toyota, T., Aruga, J., Minabe, Y., Tonegawa, S., & Yoshikawa, T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610765104 · Cited by 163
Transcriptional modulation induced by ionizing radiation: p53 remains a central player
Rashi‐Elkeles, S., Elkon, R., Shavit, S., Lerenthal, Y., Linhart, C., Kupershtein, A., Amariglio, N., Rechavi, G., Shamir, R., & Shiloh, Y. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.06.004 · Cited by 95
Metadata
- Authors
- Warner, L. E., Mancias, P., Butler, I. J., McDonald, C. M., Keppen, L., Koob, K. G., & Lupski, J. R.
- Venue
- Nature Genetics
- Published
- 1998-04
- Volume
- 18
- Issue
- 4
- Pages
- 382-384
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2047342629
- Cited by
- 500
- References
- 24
- FWCI
- 15.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.